Related Experiment Video
Updated: Sep 12, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Current Practices in Gestational Diabetes
Anna Palatnik1, Maisa N Feghali2
1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Medical College of Wisconsin, Cardiovascular Center, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
Abstract:
Despite recognized maternal and fetal risks, gaps remain in defining optimal glycemic targets, pharmacotherapy thresholds, and implementing first-line gestational diabetes mellitus (GDM) treatments. Medical nutrition therapy and 150 minutes of weekly moderate exercise are essential but face adherence challenges due to time constraints and psychological stress. Individualized support and structured guidance can enhance success. Insulin is the preferred pharmacologic option for its efficacy and safety, yet treatment must consider individual pathophysiology. With rising GDM prevalence, novel therapeutic strategies are critical to improving maternal health and ensuring the long-term well-being of affected children.
More Related Videos
06:11Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon